More than 3.6 million baits containing a recombinant vaccinia virus-rabies glycoprotein (V-RG) oral rabies vaccine were aerially or hand-distributed during 1999-2006 in an approximate 4,000-9,000 km 2 area of eastern Ontario, Canada, as part of a multitactic approach to control the raccoon variant of rabies. The efficacy of the program was assessed through the collection and testing of .6,900 animals for bait acceptance and rabies virus-specific antibodies. Raccoon acceptance of rabies vaccine baits was significantly greater (71-83%) in areas baited at a density of 150 baits/km 2 compared to areas baited at 75 baits/km 2 (26-58%), and more raccoons 
INTRODUCTION
The primary terrestrial vectors of rabies in Ontario, Canada, have been red foxes (Vulpes vulpes) and striped skunks (Mephitis mephitis) for the Arctic variant, and raccoons (Procyon lotor) for the raccoonvariant (Johnston and Beauregard, 1969; Rosatte, 1988; Rosatte et al., 2006) . The Arctic variant entered Ontario from the north during the 1950s (Johnston and Beauregard, 1969) , and the raccoon variant of rabies progressed into Ontario from New York State during 1999 (Wandeler and Salsberg, 1999; Rosatte et al., 1997 Rosatte et al., , 2001 Rosatte et al., , 2005 Rosatte et al., , 2006 . The disease has been controlled in Ontario using a variety of tactics, including oral rabies vaccination with baits (ORV), population reduction, and trap-vaccinate-release (Johnston et al., 1988; MacInnes et al., 2001; Rosatte et al., 2001 Rosatte et al., , 2007a . In addition to ORV in Ontario, vaccine baits have been distributed in New York State in adjacent areas along the St. Lawrence and Niagara rivers since 1995 (rivers act as geographic barriers to raccoon movement) to protect Ontario's borders from an invasion or reinvasion of raccoon rabies. This was a cooperative effort between New York State (Cornell University), the United States Department of Agriculture (USDA), and the Ontario Ministry of Natural Resources (OMNR). The Ontario ORV program is part of a larger campaign to distribute vaccine baits in eastern North America to control raccoon rabies for public health and economic benefits ). An application and experimental design was submitted to the Veterinary Biologics and Biotechnology Section (VBBS) of the Canadian Food Inspection Agency (CFIA), Ottawa, Ontario, during August 1999, for approval to use V-RG baits to control raccoon rabies in Ontario. Approval to use V-RG in Ontario was granted in September 1999. This paper reports on the results of the Ontario portion of the international effort to control raccoon rabies during 1999-2006 via the aerial distribution of a recombinant vaccinia virus-rabies glycoprotein oral vaccine.
MATERIALS AND METHODS

Study area
The study area, located in eastern Ontario ( Fig. 1; 44u459N, 75u509W ) is primarily rural with exposed Precambrian rock, glacial moraines, and plains with sandy deposits and some marshy areas (Wickware and Rubec, 1989) . To the south, the St. Lawrence River acts as a partial barrier to animal and disease movement; however, there are numerous islands in the river and some bridges that serve as an aid to animal movement. A total of 132 cases of raccoon-variant rabies were reported in the study area during 1999-2005, with just five cases occurring during 2004-05 (Rosatte et al., 2001 (Rosatte et al., , 2006 . Ontario has been free of reported raccoon variant rabies since 24 September 2005 (to 1 July 2008).
Vaccine bait manufacture/acquisition RABORAL V-RGH (Merial Limited, Athens, Georgia, USA) is a registered vaccine bait. The minimal protective dose for licensure of RABORAL V-RG for use in raccoons in the US is 10 7.0 Median tissue culture infective doses (TCID 50 )/ml (Merial Limited, unpubl. data) . The Fishmeal Polymer (FP) baits used in this study during 1999 were a component of the RABORAL V-RG package. Other bait types used in this study (Ontario Slim) were not RABORAL V-RG because they were manufactured from bulk V-RG vaccine acquired from Merial Limited. Bulk V-RG (titer of at least 10 8.0 TCID 50 /ml at production) was purchased from Merial Limited, shipped to Ontario in polypropylene carboys, and used to manufacture Ontario Slim (OS) baits ( Fig. 2) at Artemis Technologies Inc., Guelph, Ontario, Canada. The matrix of the OS bait consisted of 42% beef tallow (oleo), 28% MICROBONDH wax, 20% icing sugar, 8.5% vegetable oil, 1% marshmallow extract, and 0.5% dark-green, food grade, fat-soluble dye. The OS bait weighed approximately 13 g with dimensions of 35 mm 3 35 mm 3 11 mm. The polystyrene vaccine container (used during 1999-2002) , known as a blister pack, contained 1.8 ml (60.1 ml) of V-RG vaccine. Polyvinyl chloride was used to manufacture the blister pack during 2003-06. The blister pack was embedded in the matrix so that the lid of the blister pack was visible as an identification label. About 23,000 RABORAL V-RG Fishmeal Polymer (FP) baits (Fig. 2) were purchased from Merial Limited, and about 31,300 were acquired from Cornell University, Ithaca, New York, USA. RABORAL V-RG FP baits consisted of a vaccine-filled polyethylene sachet inserted into the middle of a bait matrix and weighed approximately 24 g, with dimensions of 30 mm 3 30 mm 3 20 mm. Coated Sachet (CS) baits (Fig. 2) were also acquired from Merial Limited during 2001-03. The CS was a 57 mm 3 22 mm 3 3 mm polyethylene package weighing approximately 3-4 g, which is coated on the exterior with unspecified attractant fish oil. Approximately 1.860.1 ml of V-RG is sealed within the package. The matrix of OS and RABORAL V-RG FP baits also contained 100-200 mg of tetracycline hydrochloride as a biomarker to indicate bait acceptance in raccoons, skunks, and foxes. CS baits did not contain a biomarker.
V-RG stability experiments
The titer of V-RG virus in OS and CS baits was determined over time under field conditions to verify the vaccine potency and stability. Ontario Slim and CS baits containing V-RG were placed outdoors in access-proof, steel mesh cages. Sample baits were retrieved from the cages weekly for 35 days, frozen at 280 C, and then all baits were titrated in a single assay. Day-0 baits were frozen (280 C) immediately and subsequently thawed for titration with those retrieved at the other time intervals. Day 0 was the first day 62 of ORV aerial baiting for each year tested (Tables 1 and 2 ). Titers of day-0 baits were compared with production titers (taken at time of manufacture) to determine if there was virus loss during storage between manu-facture and distribution. The V-RG titer was determined using the microtiter fluorescent antigen test (FA 50 ) on VERO cells. A standard reference virus of known titer (Std 200/700) was calibrated against the test samples to validate the assay. Titers were calculated by the methods of Spearman-Kä rber or Reed and Muench (Lorenz and Bö gel, 1973) and reported as geometric mean titer (GMT) log 10 TCID 50 /ml. Artemis Technologies, Inc. assayed V-RG using a microtiter cell culture infectious dose 50% (CCID 50 ) assay and the GMT of the triplicate results was reported as log 10 CCID 50 /ml.
Pre/Post-ORV sample collection
During a Point Infection Control Program (PIC) to contain the first case of raccoon rabies in eastern Ontario during July 1999, blood was collected from raccoons (as detailed in Rosatte et al., 2001) , which served as a control sample prior to baiting in September, 1999. In subsequent baiting campaigns, raccoons and skunks were live-trapped in trapping cells (each approximately 10 km 2 ) within the areas that were baited (OMNR-collected live samples). All trapped raccoons and skunks were processed and released according to Rosatte et al. (2001) . A second premolar tooth FIGURE 1. Location of V-RG baiting area in eastern Ontario, during 2005. In response to a single case of raccoon-variant rabies during 2005, V-RG baits were aerially distributed at 75 baits/km 2 in a 4,620 km 2 area. In addition, trap-vaccinate-release was implemented within 10 km of the case and V-RG baits were aerially distributed over a 526 km 2 area at a density of 150 baits/km 2 . This was the last reported case of raccoon rabies in Ontario that was diagnosed on 23 September 2005 (to 1 July 2008).
was also extracted from each animal using tooth extraction tools. Canine and premolar teeth were also extracted from a sample of raccoons that had been euthanized during PIC operations in 1999 and 2004. Animals (cadavers) were also collected from licensed Ontario fur trappers and hunters (cadaver samples) in baited and nonbaited areas, during all years, to assess bait acceptance and vaccine efficacy. Canine teeth and chest cavity fluids were extracted from these animals. Results are given for both live (OMNR) and cadaver samples. Second premolar teeth were examined for tetracycline presence in live samples, and canine teeth were used for biomarker determination in cadaver samples.
Bait acceptance testing and age determination
Teeth were prepared using established techniques described in Bachmann et al. (1990) and Johnston et al. (1987) . The presence of tetracycline (epi-fluorescence) was detected with a compound microscope under ultraviolet incidence light using requisite excitation and barrier filter combinations (Johnston et al., 1987) . Bait acceptance was estimated by the number of teeth exhibiting tetracycline fluorescence (Johnston et al., 1987) . In canine teeth, age was determined with a similar microscope using polarizing filters under transmitted light to distinguish age zones or annuli (via birefringence) in undecalcified tooth cementum (Johnston et al., 1987) . Premolars were decalcified and stained with hematoxylin (post-tetracycline assessment)-microscopy was under transmitted incandescent light. Number of annuli verified the animal's age (Johnston et al., 1987) .
Serology testing for rabies virus-specific antibodies
A competitive ELISA (cELISA) was used to determine rabies glycoprotein-specific antibody levels in raccoon and skunk sera as described previously (Elmgren and Wandeler, 1996) . Percent inhibition of binding of a horseradish peroxidase (HRP) labeled, glycoprotein-specific monoclonal antibody to microtiter plates coated with whole ERA virus was calculated from the ratio of the optical density of the test sample to that of a control well representing 100% binding. The positive cutoff values for each species were determined by Receiver Operating Characteristics analyses using a neutralizing titer of 0.5 IU/ml as the criterion for classifying a sample as positive (Metz, 1978) . Using virus neutralization as the reference standard, the cELISA sensitivity and specificity were 84 and 85% for raccoon sera and 91 and 95% for skunk sera, respectively.
For determination of antibody levels in chest cavity fluid obtained from trapper-acquired cadavers, a modified cELISA (blocking [b] ELISA) was used due to non-specific reactions generated by these samples in the cELISA. Using clean raccoon sera, test agreement between cELISA and bELISA tests ranged between 90% and 96%. For the bELISA, chest cavity fluid diluted in phosphate-buffered saline (1:70) was incubated on virus-coated plates overnight at 4 C. Following washing of the plates, horseradish peroxidase labeled glycoprotein-specific monoclonal antibody was added, incubated for 1.5 hr at 28 C, and then developed and analyzed as in the cELISA.
Aerial bait distribution
Baits were distributed aerially using Twin Otter (DHC-6) aircraft (De Havilland Canada Ltd., Downsview, Ontario, Canada) outfitted with specially designed baiting machines . Altitude was approximately 150 m above ground level and flight speed was approximately 250-270 km/hr. Flight lines were predetermined using GIS and AUTOCADH software and loaded into the GPS navigational system. In some baiting campaigns, baits were also distributed by hand in selected urban (green) areas and parks and on some islands. The detailed parameters of the baiting campaigns carried out from 1999 to 2006, including dates, baits types, flight line spacing, and bait density are outlined in Table 2 .
Statistical analysis
Data were analyzed using a log-linear analysis (using STATISTICAH software) to examine associations between the categorical variables: sex, maturity, flight line spacing, drop date, and bait acceptance during 2000-04 because bait density and flight line spacing were consistent among these years. Chi-square analysis was also used for post hoc comparisons and to compare differences in serology and age of raccoons from areas receiving OS or CS baits.
RESULTS
V-RG stability experiments
The production GMT (n54) of OS V-RG for all lots was within requisite for release for ORV ($7.00 log 10 TCID 50 /ml) ( Table 1) . With the exception of 2002, the day-0 GMT for OS V-RG lots was within range of the production GMT regardless of the number of days between manufacture and day-0 (first day of ORV aerial baiting); -11,-13,-14 (110-120) a NA for 1999.
b GMT 5 geometric mean titer (log 10 TCID 50 /ml), ns 5 no sample.
c Production titer is the titer at time of vaccine-bait manufacture (n54). (Table 1) . Vaccine lots manufactured in a previous year were retitrated in the year of baiting to assure requisite titers for release. Production GMT and number of days between production and day-0 refer to retest titers in those cases ( 
Animals sampled from nonbaited areas
About 13% (147/1,145) of the raccoons and 7% (2/28) of the skunks sampled from nonbaited areas were positive for tetracycline. About 3% (19/595) of the raccoons and no (0/23) skunks were antibodypositive for rabies in nonbaited areas. In addition, 7% (1/14) of the foxes sampled in nonbaited areas were antibody-positive and 37% (7/19) were tetracycline-positive.
ORV aerial-baiting campaigns
1999 Program: Based on the prevalence of tetracycline in second premolar teeth, 61% (150/248) of the raccoons sampled consumed OS baits containing V-RG (Table 3) . About 18% of sampled raccoons had rabies virus antibody as determined by a cELISA (Table 3) . Based on tetracycline prevalence in second premolar teeth, 44% (43/98) of the raccoons sampled consumed RABORAL V-RG FP baits (Table 3) . Raccoon acceptance of FP baits based on tetracycline in canine teeth was 64% (137/215). There were no detectable differences in acceptance of FP baits based on sex and age of raccoons (P50.26). About 14% of sampled raccoons had rabies virus antibody (Table 3 ). In addition, raccoon acceptance of OS baits was significantly greater (61%) than acceptance of FP baits (44%) based on tetracycline prevalence in premolar teeth (P, 0.05) ( Table 3) . (53/1,439) of trapper-acquired raccoons were both tetracycline and ELISA-positive; bELISA cut-off was 20% inhibition. d These raccoons were collected in areas baited with CS baits that did not have tetracycline in them (i.e.. the tetracycline was probably acquired outside of the baiting area and the animals dispersed into the baiting area).
paigns were carried out in June and September, and hand distribution of OS baits was carried out in towns, parks, and islands during late August (Table 2) . Greater numbers of raccoons consumed OS V-RG baits during September 2000 than during June 2000 (P50.0002; as assessed by prevalence in second premolar teeth 2.5-9 wk post-baiting; Table 3 ). Additionally, greater numbers of raccoons consumed baits in areas baited with a flight line spacing of 0.75 km compared to 1.5 km (P50.0005; P50.002 for trappersampled raccoons; Table 3 ). Serology results were low among all sampled animals with #10% of raccoons having rabies virus antibody (Table 3) .
2001: Aerial baiting with OS and CS baits was carried out in late August using bait densities of 75 and 150 baits/km 2 . In addition, hand baiting was carried out on 15 July and 31 October (see Table 2 ). Raccoon acceptance of OS baits was 83% (76/92) in areas baited at 150 baits/km 2 and 51% (134/265) at 75 baits/km 2 (P,0.001; Table 3 ). The percentage of seropositive raccoons in those areas was 11% and 7%, respectively (P50.09; Table 3). The percentage of seropositive raccoons in areas baited with CS baits (150/km 2 ) was significantly greater (27% [45/169]) than in areas baited with OS baits (11%; P50.01; Table 3 ). During additional surveillance operations (cadaver samples), 50% (217/435) and 55% (6/11) of the raccoons sampled from areas baited at 75 and 150 OS baits/km 2 , respectively, were tetracycline-positive using canine teeth. Serology values for those animals were very low (Table 3) .
During live-capture surveillance operations (6-9 weeks post-baiting), 24% (11/ 46) of the skunks sampled were tetracycline-positive in areas baited at 75 OS/ km 2 . Only three skunks were sampled in areas baited at 150 OS/km 2 -one of those was positive for tetracycline.
2002: From 16-23 August, aerial baiting with OS and CS baits was carried out using bait densities of 75 and 150 baits/ km 2 and hand baiting was carried out in cities, towns, parks, and islands of eastern Ontario (see Table 2 ). About 80% of the raccoons (92/115) trapped in areas baited at an OS bait density of 150/km 2 contacted baits (Table 3 ). This was significantly higher than the percentage of raccoons (55% [200/362] ) that were tetracyclinepositive from areas baited at 75 baits/km 2 (P,0.001). No statistically significant differences were detected in serology results for raccoons sampled from areas baited with OS (10%) or CS (18%) baits at a density of 150 baits/km 2 (P50.078). A significant association was detected between the age of raccoons that were positive for tetracycline and bait density (P,0.001). More adult than juvenile raccoons were positive for tetracycline in areas baited at 75 baits/km 2 , whereas the inverse was true in areas baited at 150 baits/km 2 . Biomarker results from raccoon cadaver samples were similar to OMNR-acquired live samples with higher acceptance rates occurring in the higherdensity baited areas (P,0.001); however, serology values for cadaver samples were very low (Table 3) .
About 27% (10/37) of the skunks trapped in areas baited with an OS bait density of 150/km 2 contacted baits as evidenced by the presence of tetracycline in second premolar tooth sections. About 15% (2/13) of the skunks sampled in areas baited at 75 baits/km 2 were tetracycline-positive (Table 4). No differences were found in skunk tetracycline positivity between the two bait densities (P50.39). Skunk bait acceptance and serology results were low for cadaver samples as well (Table 4) . However, results for foxes were more promising than in skunks (Tables 4 and 5 ).
In 2002, it was determined that the blister pack material (polystyrene) led to an increase in pH of the vaccine with a resultant loss in potency (see Table 1 Table 3 ). Trapper-acquired raccoon cadaver samples had similar results at lower bait densities (Table 3) . About 10% and 23% of the raccoons from those respective areas were positive for rabies virus antibody (P50.0003; Table 3 ). Of the raccoons that ate OS baits (as evidenced by tetracycline deposits), 16% (23/145) and 29% (44/151) were positive for rabies virus antibody in areas baited at 75 and 150 OS/km 2 , respectively. Only 16% (17/110) of the raccoons sampled in areas baited with CS baits at a density of 150/km 2 were rabies virus antibody-positive (Table 3) . That was significantly lower than the percent of raccoons that were rabies virus antibody-positive in areas baited with 150 OS baits/km 2 (P50.02). About 20% (3/15) and 54% (7/13) of the skunks sampled in areas baited at 75 and 150 OS baits/km 2 , respectively, were tetracycline-positive (P50.067; Table 4 ). (Table 2) . Bait density was 75 and 150/ km 2 and flight line spacing was 0.75 km (Table 2) . About 47% (101/213) of the raccoons (204 canine teeth; nine second premolars) sampled from areas baited at 75 baits/km 2 6-9 wk post-baiting were positive for tetracycline (Table 3) . A significant interaction was detected between the age of raccoons and tetracyclinepositive raccoons-greater numbers of adults (65% [50/77]) were tetracyclinepositive than juveniles (39% [51/131]; P,0.001). In addition, 21% (15/72) of the skunks sampled also were tetracyclinepositive using canine teeth (Table 4) . Based on a cELISA, 28% (37/133) of the raccoon sera and 16% (9/58) of the skunk sera were positive for rabies virus antibody in areas baited at 75/km 2 (Tables 3 and 4 ). Of the raccoons that were tetracyclinepositive and for which a blood sample was collected, 56% (35/63) were seropositive. No significant associations were found among age and sex of raccoons and rabies virus antibody (P,0.07). Greater numbers of raccoon cadavers from high bait density areas were tetracycline-positive than those collected from low bait density areas (P50.006; Table 3 ). However, serology results from those areas were not different (P50.18; Table 3 ). About 75% of sampled foxes were biomarker-positive; however, serology values were low (Table 5) . Table 2 ). The OS baits were additionally hand-distributed in urban areas and islands. Based on cadaver samples during 2005, bait acceptance was significantly greater in high-bait density areas compared to low-density areas but serology results were low (P50.05; Table 3 ). However, results were not different for skunk samples (P50.45; Table 4 ). Six of seven foxes were biomarker-positive during 2005 operations (Table 5) .
Among-year comparisons 2001-03
Among-year differences in bait acceptance were compared only for 2001-03 because bait density, flight line spacing, and bait type were the same for those years. At a density of 75 baits/km 2 , bait acceptance for adult raccoons was higher than for juveniles for 2 of 3 yr (2002/03; 61 and 71% for adults vs. 49 and 45% for juveniles; Table 6 ). Comparisons between sexes from 2001-03 demonstrated that bait acceptance by males was higher than that for females over the 3-yr period (Table 6) (Table 7) . However, in 2002, there was an association between tetracycline marking and age (P50.029) with adult raccoons showing 92% (35/38) acceptance when compared to juvenile raccoons at 75% (57/76; Table 7) . Analysis between sex classes demonstrated no significant differences in tetracycline marking between male and female raccoons at this density (Table 7 ). An analysis was conducted between baiting densities to determine if baiting density had an effect on tetracycline marking in raccoons. In all years, the number of tetracycline-positive raccoons was significantly higher in areas baited at 150 baits/km 2 as opposed to 75 baits/km 2 (P,0.003; Table 3 ). Among-year serology comparisons were not conducted due to the possibility that low results during some years might have been attributed to vaccine stability problems noted previously.
Bait contacts
During 1999-2006 there were 130 public enquiries regarding V-RG baits with baits being contacted by 50 dogs and 42 people. The contacts varied from people who had found baits but did not contact vaccine, people who reported dogs a Tetra+ 5 tetracycline-positive; Tetra-5 tetracycline-negative; % pos 5 the percent of raccoon teeth that were positive for tetracycline; df 5 degrees of freedom. a Tetra+ 5 tetracycline-positive; Tetra-5 tetracycline-negative; % pos 5 the percent of raccoon teeth that were positive for tetracycline; df 5 degrees of freedom.
chewing baits, and people who contacted vaccine after handling chewed baits. In cases where humans contacted vaccine, they were immediately referred to a physician; however, no further medical action was required in any of the cases. No adverse effects were noted in the six individuals who reported contacting vaccine. In 2000, a dog that ate baits became ill with diarrhea and vomiting that lasted for 2-3 days. The condition cleared up completely after that. There were no reports of ill effects in other cases of dogs ingesting baits.
Baiting costs
The estimated cost for aerially distributing V-RG baits included costs for vaccine purchase, bait manufacture, aircraft distribution, and post-baiting assessment, and is shown in (Table 8) .
DISCUSSION
More than three million V-RG baits were distributed in eastern Ontario, Canada, during 1999 -2006 . This was the first time that RABORAL V-RG as well as V-RG in OS and CS baits were used in Canada for the control of raccoon rabies. There were a minimal number of vaccinebait contacts and no human reactions to vaccine were reported. This is encouraging in terms of human and domestic pet safety.
Raccoon acceptance of vaccine baits (based on tetracycline prevalence) in eastern Ontario in this study varied between 26% and 83%, depending on bait density, bait type, flight line spacing, type of tooth used for detection of tetracycline, and the time of year for baiting. This was comparable to the 59% raccoon acceptance of baits in southcentral Ontario as reported in Rosatte and . In New Jersey, tetracycline was found in 73% of sampled raccoons following distribution of FP V-RG baits at a density of 64/km 2 (Roscoe et al., 1998) . In our study, baiting campaigns carried out in 2000 showed significantly higher bait acceptance in September as compared to June at both the high (150/ km 2 ) and low (75/km 2 ) bait densities. This result was not surprising because juveniles with insufficiently developed body size or dentition would be expected to have more difficulty than adults in chewing the baits adequately to contact vaccine. This effect could be minimized by delaying distribution of baits to later in the year when juveniles are more fully developed. In Ontario, this date is about mid-August. However, our results from baiting campaigns in years subsequent to 2000 (all carried out in mid-to late August) showed that in general, bait acceptance was higher in adult raccoons than juveniles, suggesting other factors also might influence bait acceptance. These could include difference in foraging behaviors or traveling range of adults vs. juveniles (Rosatte, 2000) , factors that also might have influenced the observed higher bait acceptance in males vs. females in areas of low bait density. Also, in our study, raccoon acceptance of baits was significantly greater in areas baited at 150 baits/km 2 as opposed to 75 baits/km 2 . Higher bait acceptance is important especially because oral vaccines are not 100% effective (based on serology and challenge studies; e.g., Rupprecht et al., 1986 Rupprecht et al., , 1988 , making it necessary to reach more raccoons with vaccine baits in order to maximize immunity against rabies in the field.
We view the bait acceptance values for raccoons in this study as minimal estimates. Previous work from our laboratory indicates that tetracycline marking in raccoon canine teeth might be more efficient than in first or second premolars, as much as 1.6 times (unpubl. data). This is probably due to size differences among the teeth, as well as different tooth extraction and sectioning techniques. However, additional research is needed due to highly variable correction factor estimations among different populations of raccoons in Ontario. It has also been shown in our laboratory that the prevalence of tetracycline in premolar and canine teeth from the same animal can be different (Sobey et al., unpubl.) . As such, bait acceptance based on second premolars might be underestimates of the actual value. It is also possible that tetracycline deposition did not occur in every animal that consumed bait. In fact, Johnston et al. (2005) found that about 40% of the tetracycline in a sample of baits used for raccoon rabies control in the US was unavailable for absorption. This means that bait acceptance using canine teeth might also represent an underestimate of actual acceptance values.
Knowledge of background tetracycline levels prior to baiting also is an asset in assessing post-baiting bait uptake (Nunan et al., 1994) . If background biomarker levels are high, an overestimate of actual bait acceptance will occur. About 13% of the raccoons and 7% of the skunks sampled from nonbaited areas were positive for tetracycline. This could represent animals dispersing from baited areas or tetracycline acquired from the environment. However, significantly greater numbers of raccoons and skunks were biomarker-positive in baited areas than in nonbaited areas. The high percentage of foxes that were tetracycline-positive in nonbaited areas is most likely attributable to the wide-ranging habits of foxes (Voigt, 1987) . Animal movement potential is very important when trying to interpret bait acceptance data. In this study, there were biomarker-positive foxes and raccoons sampled from CS baited areas (i.e., there was no biomarker in the CS baits). These animals may have eaten baits in other areas and dispersed into the CS areas. This is not unexpected because red foxes in Ontario are capable of dispersing .100 km (Voigt, 1987) , and in one study in southern Ontario, 35% of raccoons were documented as moving greater than 20 km but less than 50 km (Rosatte, 2000) . Striped skunks are much more sedentary with movements in Ontario being generally ,5 km (Rosatte and Lariviere, 2003) .
Another consideration when evaluating bait acceptance is raccoon density. If raccoon density is exceptionally high, additional baits might be needed to reach a substantial portion of the raccoon population. For example, in Toronto, Ontario, where raccoon density averaged about 13-20/km 2 (Rosatte, 2000) , 400 baits/km 2 yielded bait acceptance values of 82% in raccoons (Rosatte and Lawson, 2001 Rosatte et al., 2001 Rosatte et al., , 2007b , and comparable bait acceptance levels could be achieved at a bait density of 150/km 2 . However, there were landscape differences (urban vs. rural) between those areas that might have had some impact on acceptance values due to raccoon dispersion across the landscape and varying available sustenance.
It is clear that a substantial portion of the studied raccoon populations could be enticed to consume baits containing V-RG. However, that did not equate to a similar percentage of the population developing a detectable immune response against rabies virus. The serology results from this study were lower than expected based on published reports, with seroconversion in 7-28% of sampled raccoons, depending on year, bait type, bait density and flight line spacing. These data are inconsistent with results from laboratory efficacy trials, where 80 to 100% of raccoons orally immunized with V-RG seroconverted and were subsequently protected following challenge with rabies virus (Rupprecht et al., 1986 (Rupprecht et al., , 1995 . There has been a great deal of variation in the reported field efficacy of V-RG in raccoons and it is noted that a variety of serologic tests have been utilized, which will affect the comparison of the results among study areas. Robbins et al. (1998) found that 37, 67, and 77% of the sampled raccoons in three treatment areas in Massachusetts had rabies virus antibody. Roscoe et al. (1998) found that 61% of sampled raccoons were seropositive following distribution of V-RG baits in New Jersey. About 52% of a sample of raccoons on Parramore Island, Virginia, where V-RG had been distributed at a density of 1,000 baits/km 2 during 1990, was seropositive for rabies virus antibody (Hanlon et al., 1998) . Even at this extremely high bait density, seroconversion was significantly lower than the bait acceptance of 84% determined by tetracycline deposition (Hanlon et al., 1998) . Thus, the seroconversion rates observed in the laboratory are not necessarily reflective of the results obtained from field trials.
It is not entirely clear why the Ontario baiting campaigns yielded such low seropositive rates given the reported success of V-RG in laboratory trials (Rupprecht et al., 1986 . However, because the sensitivity and specificity of the cELISA used in our study were greater or equal to 84% for raccoon and skunk sera when compared with a conventional virus neutralization assay, the observed poor correlation between seropositivity and V-RG bait acceptance was not due to use of an inadequate serologic test. Problems with vaccine stability identified in OS baits distributed in 2001/02 and CS baits distributed in 2003 likely contributed to low seropositive rates in these campaigns. Our results also suggest there might have been some problems in delivering the vaccine from the bait to the sites in the oral cavity required for the development of an immune response. Even after vaccine stability problems had been corrected, vaccine efficacy was only 56% during 2004. Additional research is needed to ensure that vaccine contact via bait consumption is maximized in the oral cavity.
The timing of sample collection for serology also might have had an impact on the detection of seropositive raccoons. One can assume that bait contact by raccoons is rapid because 83% of rabies vaccine baits placed in Ohio, and 80% in Ontario, disappeared within 1 and 2 wk of placement, respectively (Bachmann et al., 1990; Blackwell et al., 2004) . In addition, it has been shown that rabies virus antibody can be detected in raccoons and skunks as early as 5 days post-vaccination (IM) (Rosatte et al., 1990) . Hanlon et al. (1998) showed that detection of a rabies virus-specific serologic response in raccoons was optimal 4-6 wk following field distribution of V-RG baits, although responses (.0.5 IU/ml) could be detected between 2 and 12 wk. In the present study, sampling in most campaigns began 5 to 6 wk post-baiting, although in some years the sampling period ranged from 2 to 9 wk post-baiting. Therefore, it is possible that some seropositive animals were missed if they were sampled before or after the peak immune response. That is, cadaver samples were collected during winter several months post-baiting when antibody might not be as detectable as in those samples collected by OMNR staff 5-6 wk post-baiting. This was evidenced by the lower serology results for cadaver samples in Table 3 . Also, animals collected as cadaver samples might have dispersed previously either into or out of the baiting area. Although the focus of the V-RG vaccination campaigns was the control of rabies in raccoons, we took the opportunity to look at bait acceptance and seroconversion in striped skunks and red foxes as well. Fox acceptance of V-RG baits was good. This was anticipated because baits were distributed at densities greater than those usually used to target foxes (20/km 2 ; MacInnes et al., 2001) . Low serology results for foxes in this study were unexpected because V-RG has been proven to effectively immunize foxes against rabies as reviewed by Rosatte et al. (2007b) . In all likelihood, low seropositive rates for foxes in this study were due to vaccine stability problems noted previously. The observed poor bait acceptance among striped skunks was anticipated because skunks are not as wide-ranging as raccoons (Rosatte, 2000; Rosatte and Lariviere, 2003) . Thus the bait densities employed were inadequate to reach a good proportion of the skunk population. Post-baiting assessments of seroconversion were conducted following just three of the campaigns; rabies specific antibody was found in only 2-16% of the skunks sampled. The OS, FP, and CS baits used in this study were designed to deliver vaccine to raccoons, an animal with larger body size and dentition than skunks, likely accounting for the low seropositivity rates in skunks. This is consistent with the results of Grosenbaugh et al. (2007) who found that four of six skunks administered V-RG by direct oral instillation were protected from challenge, whereas those consuming coated sachet baits containing V-RG had low survival rates following rabies challenge. Results from a recent study of rabies vaccine uptake by captive striped skunks have also suggested modification of rabies vaccine baits, including reduction in size, would allow skunks to more easily puncture the vaccine container (Jojola et al., 2007) .
Our data suggest that as an ORV tactic, a density of between 75 and 150 baits/ km 2 , a flight line spacing of 0.75 km, and a baiting time of mid-August should be adequate to reach a substantial portion of the raccoon population in eastern Ontario. Costs for ORV using V-RG baits in this study varied between $147.00/km 2 and $273.00/km 2 (Cdn) with bait density being the primary cost determinant. This is comparable to the costs incurred in Ohio during 1997-2000, where costs for baiting at densities of 79-93 baits/km 2 ranged between $102.00 and $261.00/km 2 (US) (mean $153.00/km 2 ; about $180.00/ km 2 Cdn during 2006) (Foroutan et al., 2002) . It is estimated that rabies prevention costs in the US are about $230 million to $1 billion (US) annually (Rupprecht et al., 1995; Recuenco et al., 2007) . Because the raccoon rabies enzootic area covers an approximate 1 million km 2 area in eastern North America (Rosatte et al., 2001) , rabies control costs in the $150.00 to $300.00/km 2 range are reasonable and worth the investment with substantial benefits to be gained if the disease is controlled (Kemere et al., 2002) . For example, the costs for the V-RG baiting program, as well as TVR and PIC during 1999-2005 in Ontario averaged about $2 million/yr Cdn. The estimated cost if raccoon rabies became epizootic in Ontario is conservatively an additional $8 million-$12 million Cdn annually due to increased costs for human postexposure treatments (2,000-4,000), rabid animal diagnoses (1,500-2,000 cases) as well as costs to investigate suspect rabid animal incidents (Rosatte et al., 2001) . Thus the annual savings to Ontario during 1999-2005 is estimated at about $6 million-$10 million Cdn/yr. V-RG has been used extensively for the oral immunization of raccoons against rabies in the United States (Rupprecht et al., 1986 (Rupprecht et al., , 2004 Hanlon et al., 1993 Hanlon et al., , 1998 Slate et al., 2005) , in Europe for the control of rabies in foxes (Aubert et al., 1994) , and in Texas for the control of rabies in coyotes (Canis latrans) and gray foxes (Urocyon cineroargenteus) (Fearneyhough et al., 1998) . Although V-RG has proved effective for control of rabies in foxes and coyotes, it is less clear whether V-RG has been effective in the field for raccoon rabies control. Despite the widespread use of V-RG in the eastern US, raccoon rabies had become enzootic over an approximately 1 million km 2 area by the late 1990s (Jenkins and Winkler, 1987; Winkler and Jenkins, 1991) . In contrast, the eastern Ontario raccoon rabies outbreaks that began in 1999 appear to have been well-controlled with no new cases detected since September 2005, despite high raccoon densities (Wandeler and Salsberg, 1999; Rosatte et al., 2001 Rosatte et al., , 2005 Rosatte et al., , 2006 . The strategy for controlling the raccoon variant of rabies in Ontario included the use of three different tactics; population reduction (PR), trap-vaccinate-release (TVR), and oral rabies vaccination with V-RG baits (ORV). The first line of defense within 10 km of any case of raccoon rabies was PR and Trap-Vaccinate release (Rosatte et al., 2001 ). This tactic was effective in removing animals that were clinically rabid or incubating rabies for which vaccination is not effective. Trap-vaccinate-release was effective because a significant portion of the vector population could be vaccinated and the intramuscularly injected vaccine was extremely effective (Rosatte et al., 1992 (Rosatte et al., , 1993 (Rosatte et al., , 2001 ). The second line of defense, TVR, was also used proactively and reactively along the St. Lawrence River as well as in the Niagara region of Ontario (Rosatte et al., 2007b) . The ORV with V-RG baits was used as the third line of defense on the perimeter of PR and TVR areas because the vaccine used orally was not as effective as the IM injected vaccine used in TVR, but ORV was cost effective for covering large geographic areas. When we used PR, TVR, and ORV to contain a case(s) of raccoon rabies, we called this point infection control. This multi-tactic approach to raccoon rabies control in Ontario, each tactic with its own advantages, was probably a wise strategy because if containment failed, the disease could have moved very rapidly across southern Ontario (100,000 km 2 area) due to high raccoon population densities (Robbins et al., 1998; Rosatte, 2000; Rosatte et al., 1991 Rosatte et al., , 2001 Rosatte et al., , 2007b .
It is not clear what the relative contribution of each tactic (PR, TVR, ORV, or PIC) was to the overall efficacy of the Ontario rabies control program; however, if PR and TVR were not employed, in all likelihood, rabies would have spread rapidly across the province. What is known is that the raccoon variant of rabies has not been reported in Ontario since September 2005 (to 1 July 2008) and appears to be under control. Bait acceptance and serologic results from the present ORV study suggest that distribution of V-RG in the field as the sole tactic for raccoon rabies control in Ontario likely would not have been effective. It is evident that additional research is needed to increase knowledge regarding the factors influencing the success or failure of wildlife oral rabies vaccination programs. Given the high raccoon densities in Ontario and the continued threat of movement of raccoon rabies from enzootic regions of the US as well as eastern Canada, the data presented here also indicate that investigation of new or improved vaccines for the oral immunization of raccoons is warranted.
